Nicolas Barry Delongchamps
Papers
2
Total Citations
68
H-Index
2
About
Nicolas Barry Delongchamps is a leading urological surgeon and researcher whose work centers on advancing minimally invasive treatments for benign prostatic obstruction (BPO). His major contributions lie in evaluating and refining novel surgical techniques to improve outcomes for patients with benign prostatic hyperplasia (BPH). Notably, he spearheaded the first French Aquablation clinical registry, demonstrating the safety and efficacy of waterjet ablation therapy for small- to medium-size prostate glands. His landmark 2019 study, cited over 60 times, reported 12-month results showing significant symptom relief and low complication rates, establishing Aquablation as a viable alternative to traditional surgery. Delongchamps has also authored comprehensive reviews on emerging interventional and surgical approaches for BPO, synthesizing evidence to guide clinical practice. His work has been instrumental in validating Aquablation’s role in urology, earning him recognition as a key figure in the shift toward less invasive, tissue-sparing treatments. With a focus on patient-centered outcomes and procedural innovation, Delongchamps continues to shape the future of BPH management, making his research essential reading for urologists and trainees alike.
Research Focus
Key Achievements
Top Papers
- 1
- 2